Contact Us: 1-800-981-9883
On May 2, 2023, executives from various organizations across the nation will convene in Fort Worth, Texas to examine ways in which they might collaborate to alleviate the laboratory workforce shortage. According to recent studies, laboratories struggle to fill vacant positions. Professionals in the laboratory are overworked. In the aftermath of a three-year pandemic that…
COLA, a national laboratory accreditor dedicated to promoting health and safety through accreditation and education, announces Nirali M. Patel, MD, has been elected to its Board of Directors. Dr. Patel joins COLA’s board of prominent professionals appointed by the American Medical Association (AMA), American Academy of Family Physicians (AAFP) and the American College of Physicians…
COLA, a national laboratory accreditor dedicated to promoting health and safety through accreditation and education, announces the American Medical Association’s (AMA) appointment of Madelyn E. Butler, MD, to its Board of Directors. Dr. Butler joins COLA’s board of prominent physicians appointed by the AMA, American Academy of Family Physicians (AAFP) and the American College of…
COLA, a national laboratory accreditor dedicated to promoting health and safety through accreditation and education, announces Mary J. James, MD, has been elected to its Board of Directors. Dr. James joins COLA’s board of prominent professionals appointed by the American Medical Association (AMA), American Academy of Family Physicians (AAFP) and the American College of Physicians…
On September 9, 2022, the CDC alerted laboratories that the U.S. Department of Health and Human Services (HHS) has declared that the current circumstances justify the authorization of emergency use of in vitro diagnostics to detect and/or diagnose infection with the Monkeypox virus.
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On September 27, 2022, the CDC alerted laboratories that the Food and Drug Administration had updated its COVID-19 test policy to encourage most test developers to pursue…
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On September 15, 2022, the CDC alerted laboratories that the CDC’s Division of Select Agents and Toxins (DSAT) posted a Select Agent (SA) Gram to clarify the regulatory status…
COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. On September 9, 2022, the CDC alerted laboratories that the U.S. Department of Health and Human Services (HHS) has declared that the current circumstances justify the authorization…
